Low molecular weight heparin
Low molecular weight heparin is a pharmaceutical drug with 40 clinical trials. Currently 1 active trials ongoing. Historical success rate of 78.6%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
19
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
73.3%
11 of 15 finished
26.7%
4 ended early
1
trials recruiting
40
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk
Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)
Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)
Role of Low-Molecular-Weight Heparin in Unexplained Recurrent Pregnancy Loss
Clinical Trials (40)
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk
Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)
Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)
Role of Low-Molecular-Weight Heparin in Unexplained Recurrent Pregnancy Loss
Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula
Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.
Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)
Prospective Study of BMD and Ca-P Metabolism in RSA Patients: LMWH Use Versus Control
Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices
Ultra Low Doses of Therapy With Radiation Applicated to COVID-19
Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19
STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism
Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization
Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19
Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT)
Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto
Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome
Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves
Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 40